William M. McClements, Head of Corporate Operations at MERRIMACK PHARMACEUTICALS INC (MACK), bought 2,000 shares at $5.72 ($11K) on 2016-02-29, disclosed to the SEC on 2016-03-01.
Open-market purchase of $11k MACK by Head of Corporate Operations. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| MACK | BUY | 2013-12-02 | $25K | — | Filing → |